Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Getinge ABOSTO:GETI B +0.52%81 FCF Margin % is 11.87% as of Jun. 2026, which is 38% above its 10-year median of 8.60. GuruFocus rates OSTO:GETI B with a GF Score™ of 81/100 and a GF Value™ of kr205.32 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Getinge AB ranks better than 76.2% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Getinge AB's Free Cash Flow for the
three
months ended in Jun. 2026 was kr995 Mil. Getinge AB's Revenue for the
three
months ended in Jun. 2026 was kr8,381 Mil. Therefore, Getinge AB's FCF Margin % for the quarter that ended in Jun. 2026 was 11.87%.
The historical rank and industry rank for Getinge AB's FCF Margin % or its related term are showing as below:
OSTO:GETI B'
s FCF Margin % Range Over the Past 10 Years
Min: 4.65 Med: 8.6 Max: 20.81
Current: 11.11
During the past 13 years, the highest FCF Margin % of Getinge AB was 20.81%. The lowest was 4.65%. And the median was 8.60%.
OSTO:GETI B's FCF Margin % is ranked better than 76.2% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs OSTO:GETI B: 11.11
Getinge AB FCF Margin % Related Terms
Getinge AB FCF Margin % Historical Data
* Premium members only.
The historical data trend for Getinge AB's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:GETI B vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Getinge AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Getinge AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Getinge AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Getinge AB (OSTO:GETI B) has a FCF Margin % of 11.87% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Getinge AB and its competitors. This is 38% above median its historical median of 8.60. Over the past decade, Getinge AB's FCF Margin % has ranged from 4.65 to 20.81. According to the industry distribution chart, Getinge AB ranks #194 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 23.8%.
Is Getinge AB's FCF Margin % too high?
Getinge AB's current FCF Margin % of 11.87% is 38% above median its 10-year median of 8.60. Over the past 10 years, this metric has ranged from a low of 4.65 to a high of 20.81. Based on the distribution chart, Getinge AB ranks #194 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Getinge AB has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Getinge AB ranks #194 out of 815 companies for FCF Margin %. This places Getinge AB in the top 24% of its industry — outperforming the majority of peers. Historically, Getinge AB's own FCF Margin % has ranged from 4.65 to 20.81 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Getinge AB and its competitors. Getinge AB's current FCF Margin % is 11.87%, which is 38% above median its own 10-year median of 8.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (OSTO:GETI B) is currently considered Modestly Overvalued. The stock's GF Value™ is kr205.32, compared to a current price of kr230.30 — trading 12.2% above its estimated fair value. The current FCF Margin % is 11.87%, which is 38% above median its 10-year median of 8.60. Getinge AB's overall GF Score™ is 81/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Getinge AB (OSTO:GETI B), the current FCF Margin % is 11.87% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Getinge AB (OSTO:GETI B) Overvalued in 2026?
Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued.
The current stock price of kr230.30 is trading 12.2% above its estimated GF Value™ of kr205.32.
GuruFocus considers Getinge AB to be Modestly Overvalued.
Key valuation signals for OSTO:GETI B:
FCF Margin %: 11.87% (38% above median its 10-year median of 8.60)
GF Value™: kr205.32 vs. price of kr230.30 (12.2% above fair value)
No single metric tells the full story. See the OSTO:GETI B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
81GF Score
Get the complete analysis for OSTO:GETI B
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:GETI B has been successfully added to your 
